Business Description
Enzychem Lifesciences Corp
ISIN : KR7183490002
Compare
Compare
Traded in other countries / regions
183490.Korea IPO Date
2013-09-25Description
Enzychem Lifesciences Corp develops and produces APIs and functional health foods. It manufactures veterinary medicine tablets, capsules, syrups, injections, ointments, solutions for the diagnosis and prevention of various diseases. The company is also developing drugs to treat chemotherapy-induced neutropenia, chemo-radiation therapy-induced oral mucositis, asthma, psoriasis, rheumatoid arthritis, and others.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 27.07 | |||||
| Equity-to-Asset | 0.93 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | -0.76 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 6.67 | |||||
| Beneish M-Score | -1.18 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 28.9 | |||||
| 3-Year EBITDA Growth Rate | 35.7 | |||||
| 3-Year EPS without NRI Growth Rate | 27.8 | |||||
| 3-Year FCF Growth Rate | 18.9 | |||||
| 3-Year Book Growth Rate | 25.3 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 49.36 | |||||
| 9-Day RSI | 41.31 | |||||
| 14-Day RSI | 40.16 | |||||
| 12-1 Month Momentum % | 0.12 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 14.43 | |||||
| Quick Ratio | 13.06 | |||||
| Cash Ratio | 10.43 | |||||
| Days Inventory | 67.44 | |||||
| Days Sales Outstanding | 49.28 | |||||
| Days Payable | 24.04 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -10.8 | |||||
| Shareholder Yield % | 19.48 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 6 | |||||
| Operating Margin % | -15.68 | |||||
| Net Margin % | -10.51 | |||||
| FCF Margin % | -11.1 | |||||
| ROE % | -4.65 | |||||
| ROA % | -4.26 | |||||
| ROIC % | -19.26 | |||||
| 3-Year ROIIC % | 7.37 | |||||
| ROC (Joel Greenblatt) % | -20.37 | |||||
| ROCE % | -4.67 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.45 | |||||
| PB Ratio | 0.65 | |||||
| Price-to-Tangible-Book | 0.69 | |||||
| EV-to-EBIT | -0.49 | |||||
| EV-to-EBITDA | -0.79 | |||||
| EV-to-Revenue | 0.05 | |||||
| EV-to-FCF | -0.47 | |||||
| Price-to-Net-Current-Asset-Value | 0.83 | |||||
| Price-to-Net-Cash | 1.19 | |||||
| Earnings Yield (Greenblatt) % | -204.08 | |||||
| FCF Yield % | -8.08 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Enzychem Lifesciences Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 84,826.494 | ||
| EPS (TTM) (â‚©) | -106 | ||
| Beta | 1.45 | ||
| Volatility % | 47.45 | ||
| 14-Day RSI | 40.16 | ||
| 14-Day ATR (â‚©) | 67.076921 | ||
| 20-Day SMA (â‚©) | 1567.1 | ||
| 12-1 Month Momentum % | 0.12 | ||
| 52-Week Range (â‚©) | 1110 - 2220 | ||
| Shares Outstanding (Mil) | 80.02 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Enzychem Lifesciences Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Enzychem Lifesciences Corp Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Enzychem Lifesciences Corp Frequently Asked Questions
What is Enzychem Lifesciences Corp(XKRX:183490)'s stock price today?
The current price of XKRX:183490 is â‚©1515.00. The 52 week high of XKRX:183490 is â‚©2220.00 and 52 week low is â‚©1110.00.
When is next earnings date of Enzychem Lifesciences Corp(XKRX:183490)?
The next earnings date of Enzychem Lifesciences Corp(XKRX:183490) is .
Does Enzychem Lifesciences Corp(XKRX:183490) pay dividends? If so, how much?
Enzychem Lifesciences Corp(XKRX:183490) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers